ACE and Abnormal renal physiology: The optimal dose of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor antagonists (ARA II) reduces albuminuria or proteinuria and decreases the development of renal dysfunction more than placebo.